1. Home
  2. LNT vs MEDP Comparison

LNT vs MEDP Comparison

Compare LNT & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliant Energy Corporation

LNT

Alliant Energy Corporation

N/A

Current Price

$70.21

Market Cap

18.5B

Sector

Utilities

ML Signal

N/A

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

N/A

Current Price

$607.68

Market Cap

15.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LNT
MEDP
Founded
1917
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Commercial Physical & Biological Resarch
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
15.4B
IPO Year
1999
2016

Fundamental Metrics

Financial Performance
Metric
LNT
MEDP
Price
$70.21
$607.68
Analyst Decision
Buy
Hold
Analyst Count
10
12
Target Price
$74.56
$473.17
AVG Volume (30 Days)
2.6M
329.1K
Earning Date
04-30-2026
04-22-2026
Dividend Yield
2.97%
N/A
EPS Growth
16.73
20.98
EPS
0.87
8.53
Revenue
$4,362,000,000.00
N/A
Revenue This Year
$4.61
$13.19
Revenue Next Year
$6.33
$7.75
P/E Ratio
$80.44
$69.20
Revenue Growth
9.57
N/A
52 Week Low
$63.28
$373.00
52 Week High
$78.81
$677.90

Technical Indicators

Market Signals
Indicator
LNT
MEDP
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
LNT
MEDP

About LNT Alliant Energy Corporation

Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light. Together, IPL and WPL serve nearly 1 million electric customers and 425,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: